Open Access
| Numéro |
Med Sci (Paris)
Volume 37, Numéro 10, Octobre 2021
|
|
|---|---|---|
| Page(s) | 848 - 850 | |
| Section | Le Magazine | |
| DOI | https://doi.org/10.1051/medsci/2021134 | |
| Publié en ligne | 14 octobre 2021 | |
- Borie AM, Dromard Y, Guillon G, et al. Correction of vasopressin deficit in the lateral septum ameliorates social deficits of mouse autism model. J Clin Invest 2021; 131 : e144450. [Google Scholar]
- Oztan O, Garner JP, Partap S, et al. Cerebrospinal fluid vasopressin and symptom severity in children with autism. Ann Neurol 2018 ; 84 : 611–615. [CrossRef] [PubMed] [Google Scholar]
- Parker KJ, Oztan O, Libove RA, et al. A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism. Sci Transl Med 2019; eaau7356. [CrossRef] [PubMed] [Google Scholar]
- Bolognani F, del Valle Rubido M, Squassante L, et al. A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder. Sci Transl Med 2019; eaat7838. [CrossRef] [PubMed] [Google Scholar]
- Tauber M, Boulanouar K, Diene G, et al. The use of oxytocin to improve feeding and social skills in infants with Prader-Willi syndrome. Pediatrics 2017 ; 139 : e20162976. [CrossRef] [PubMed] [Google Scholar]
- Bernaerts S, Boets B, Bosmans G, et al. Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up. Mol Autism 2020; 11 : 6. [CrossRef] [PubMed] [Google Scholar]
- Schaaf CP, Gonzalez-Garay ML, Xia F, et al. Truncating mutations of MAGEL2 cause Prader-Willi phenotypes and autism. Nat Genet 2013 ; 45 : 1405–1408. [CrossRef] [PubMed] [Google Scholar]
- Meziane H, Fabienne S, Sylvian B, et al. An early postnatal oxytocin treatment prevents social and learning deficits in adult mice deficient for Magel2, a gene involved in Prader-Willi syndrome and autism. Biol Psy 2015 ; 78 : 85–94. [Google Scholar]
- Schaller F, Watrin F, Sturny R, et al. A single postnatal injection of oxytocin rescues the lethal feeding behaviour in mouse newborns deficient for the imprinted Magel2 gene. Hum Mol Genet 2010 ; 19 : 4895–4905. [CrossRef] [PubMed] [Google Scholar]
- Rigney N, Whylings J, Mieda M, et al. Sexually dimorphic vasopressin cells modulate social investigation and communication in sex-specific ways. eNeuro 2019; 6 : eneuro.0415-18.2019. [Google Scholar]
- Chini B, Manning M, Guillon G. Affinity and efficacy of selective agonists and antagonists for vasopressin and oxytocin receptors: an ‘easy guide’ to receptor pharmacology. Prog Brain Res 2008 ; 170 : 513–517. [CrossRef] [PubMed] [Google Scholar]
- Peñagarikano O, Lázaro MT, Lu X-H, et al. Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism. Sci Transl Med 2015; 21 : 271ra8. [Google Scholar]
- Bales KL, Plotsky PM, Young LJ, et al. Neonatal oxytocin manipulations have long-lasting, sexually dimorphic effects on vasopressin receptors. Neuroscience 2007 ; 144 : 38–45. [CrossRef] [PubMed] [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.